Skip to main content
Premium Trial:

Request an Annual Quote

Marina Closes Financing with Potential Value of $8.7M

Premium

Marina Biotech said this week that it has completed a previously announced financing to sell up to $8.7 million shares of common stock.

The company said it sold approximately 1.8 million shares of its common stock at $1.84 per share in an initial financing with gross proceeds of $3.3 million.

Investors taking part in the stock offering also received a subscription unit to purchase up to an additional 2.4 million shares at any time up to 16 months after the initial closing for no greater than $2.21 per share. This could yield as much as $5.4 million in additional gross proceeds.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.